Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U1 small nuclear 36, pseudogene (abbreviated as RNU1-36P) is classified as a pseudogene of the U1 small nuclear RNA gene family. Unlike functional U1 snRNA genes, which are integral to the spliceosome complex and required for pre-mRNA splicing, pseudogenes such as RNU1-36P are generally non-functional and do not encode a biologically active RNA or protein product. There is no current evidence indicating functional or pathological roles for RNU1-36P, nor is it a therapeutic target for drugs or disease intervention. Its primary listing in genomic databases is for annotation purposes, and it is not a validated or established molecular target in biomedical research or therapeutic development[1][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U1 small nuclear 36, pseudogene (RNU1-36P).